Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;11(12):379-387.
doi: 10.5489/cuaj.4590. Epub 2017 Nov 1.

The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians

Affiliations

The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians

Jennifer Jones et al. Can Urol Assoc J. 2017 Dec.

Abstract

It is critically important to define disease-specific research priorities to better allocate limited resources. There is growing recognition of the value of involving patients and caregivers, as well as expert clinicians in this process. To our knowledge, this has not been done this way for kidney cancer. Using the transparent and inclusive process established by the James Lind Alliance, the Kidney Cancer Research Network of Canada (KCRNC) sponsored a collaborative consensus-based priority-setting partnership (PSP) to identify research priorities in the management of kidney cancer. The final result was identification of 10 research priorities for kidney cancer, which are discussed in the context of current initiatives and gaps in knowledge. This process provided a systematic and effective way to collaboratively establish research priorities with patients, caregivers, and clinicians, and provides a valuable resource for researchers and funding agencies.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Dr. Bhatt has received honoraria from Astellas U.K. Dr. Laupacis has been an advisor for Novartis. Dr. Basappa has been an advisor for Astellas, AstraZeneca, BI, BMS, Janssen, Novartis, and Pfizer; and has received honoraria from Astellas, BMS, Janssen, Novartis, and Pfizer. Dr. Canil has attended advisory boards for Bayer, BMS, Esai, Merck, Pfizer and Roche; has been a speaker for Bayer and Sanofi; and has received sponsorship for an international preceptorship from Pfizer. Dr. Al-Asaaed has been an advisor for Janssen and Pfizer; has received grants/honoraria from Amgen, Astellas, Celgene, Novartis, and Pfizer; and has participated in clinical trials supported by Janssen. Dr. Heng has been an advisor for BMS, Novartis, and Pfizer. Dr. Wood has been an advisor for Astellas, Novartis, and Pfizer, but received no financial compensation; and has participated in clinical trials supported by AstraZeneca, BMS, Exelixis, Merck, Pfizer, and Roche. Dr. Kollmannsberger has been an advisor for Astellas, BMS, Novartis, Pfizer, and Roche; has received presentation honoraria from BMS, Pfizer, and Novartis; and has participated in clinical trials supported by Astellas, AstraZeneca, BMS, Janssen, Merck, Novartis, Pfizer, and Sanofi. The remaining authors report no competing personal or financial interests.

Figures

Fig. 1
Fig. 1
Priority-setting process algorithm.

References

    1. Caron-Flinterman JF, Broerse JE, Bunders JE. The experiential knowledge of patients: A new resource for biomedical research? Soc Sci Med. 2005;60:2575–84. doi: 10.1016/j.socscimed.2004.11.023. - DOI - PubMed
    1. Entwistle VA, Renfrew MJ, Yearley S, et al. Lay perspectives: Advantages for health research. BMJ. 1998;316:463–6. doi: 10.1136/bmj.316.7129.463. - DOI - PMC - PubMed
    1. Goodare H, Lockwood S. Involving patients in clinical research improves the quality of research. BMJ. 1999;319:724–5. doi: 10.1136/bmj.319.7212.724. - DOI - PMC - PubMed
    1. CIHR. International review panel report 2011. [Accessed October 31, 2017]. [cited 2014 August 10]. Available from: http://www.cihr-irsc.gc.ca/e/43993.html.
    1. CIHR. Canada’s strategy for patient-oriented research: Improving health outcomes through evidence-informed care. 2013. [Accessed October 31, 2017]. [cited 2013 September 27]. Available from: http://www.cihr-irsc.gc.ca/e/44000.html.

LinkOut - more resources